泌尿外科移动健康应用程序的现状:对市场和文献中的移动平台的回顾。

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY
Ali Talyshinskii, Guliev Bakhman, Bm Zeeshan Hameed, Amelia Pietropaolo, Nithesh Naik, Bhaskar K Somani
{"title":"泌尿外科移动健康应用程序的现状:对市场和文献中的移动平台的回顾。","authors":"Ali Talyshinskii,&nbsp;Guliev Bakhman,&nbsp;Bm Zeeshan Hameed,&nbsp;Amelia Pietropaolo,&nbsp;Nithesh Naik,&nbsp;Bhaskar K Somani","doi":"10.1177/17562872231176368","DOIUrl":null,"url":null,"abstract":"<p><p>Several mobile healthcare (mHealth) apps are available in various marketplaces, but there is still concern about their accuracy, data safety, and regulation. The goal of this review was to critically analyze the mobile apps created for education, diagnosis, and medical and surgical treatment of patients with kidney stone disease (KSD), as well as to assess the level of data security, the contribution of physicians in their development and adherence to the Food and Drug Administration (FDA) and Medical Device Regulation (MDR) guidance. A comprehensive literature search was performed using PubMed (September 2022), in the Apple App Store and Google Play store using relevant keywords and inclusion criteria. Information was extracted for the name of the app, primary and additional functionalities, release and last update, number of downloads, number of marks and average rating, Android/iOS compatibility, initial and in-app payments, data safety statement, physician involvement statement, and FDA/MDR guidance. A total of 986 apps and 222 articles were reviewed, of which based on the inclusion, 83 apps were finally analyzed. The apps were allocated to six categories about their primary purpose: education (<i>n</i> = 8), fluid trackers (<i>n</i> = 54), food content description and calculators (<i>n</i> = 11), diagnosis (<i>n</i> = 3), pre- and intra-operative application (<i>n</i> = 4), and stent trackers (<i>n</i> = 2). Of these apps, the number of apps supported for Android, iOS, and both of them were 36, 23, and 23, respectively. Despite a wide range of apps available for KSD, the participation of doctors in their development, data security, and functionality remains insufficient. Further development of mHealth should be carried out properly under the supervision of urological associations involving patient support groups, and these apps must be regularly updated for their content and data security.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b1/e4/10.1177_17562872231176368.PMC10240556.pdf","citationCount":"0","resultStr":"{\"title\":\"Current state of mobile health apps in endourology: a review of mobile platforms in marketplaces and literature.\",\"authors\":\"Ali Talyshinskii,&nbsp;Guliev Bakhman,&nbsp;Bm Zeeshan Hameed,&nbsp;Amelia Pietropaolo,&nbsp;Nithesh Naik,&nbsp;Bhaskar K Somani\",\"doi\":\"10.1177/17562872231176368\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Several mobile healthcare (mHealth) apps are available in various marketplaces, but there is still concern about their accuracy, data safety, and regulation. The goal of this review was to critically analyze the mobile apps created for education, diagnosis, and medical and surgical treatment of patients with kidney stone disease (KSD), as well as to assess the level of data security, the contribution of physicians in their development and adherence to the Food and Drug Administration (FDA) and Medical Device Regulation (MDR) guidance. A comprehensive literature search was performed using PubMed (September 2022), in the Apple App Store and Google Play store using relevant keywords and inclusion criteria. Information was extracted for the name of the app, primary and additional functionalities, release and last update, number of downloads, number of marks and average rating, Android/iOS compatibility, initial and in-app payments, data safety statement, physician involvement statement, and FDA/MDR guidance. A total of 986 apps and 222 articles were reviewed, of which based on the inclusion, 83 apps were finally analyzed. The apps were allocated to six categories about their primary purpose: education (<i>n</i> = 8), fluid trackers (<i>n</i> = 54), food content description and calculators (<i>n</i> = 11), diagnosis (<i>n</i> = 3), pre- and intra-operative application (<i>n</i> = 4), and stent trackers (<i>n</i> = 2). Of these apps, the number of apps supported for Android, iOS, and both of them were 36, 23, and 23, respectively. Despite a wide range of apps available for KSD, the participation of doctors in their development, data security, and functionality remains insufficient. Further development of mHealth should be carried out properly under the supervision of urological associations involving patient support groups, and these apps must be regularly updated for their content and data security.</p>\",\"PeriodicalId\":23010,\"journal\":{\"name\":\"Therapeutic Advances in Urology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b1/e4/10.1177_17562872231176368.PMC10240556.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17562872231176368\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872231176368","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在各种市场上都有一些移动医疗(mHealth)应用程序,但人们仍然担心它们的准确性、数据安全性和监管问题。本综述的目的是批判性地分析为肾结石疾病(KSD)患者的教育、诊断、医疗和手术治疗而创建的移动应用程序,并评估数据安全水平、医生在其开发中的贡献以及对食品和药物管理局(FDA)和医疗器械法规(MDR)指南的遵守情况。使用PubMed(2022年9月),在Apple App Store和Google Play商店中使用相关关键词和纳入标准进行了全面的文献检索。提取的信息包括应用名称、主要和附加功能、发布和最后更新、下载次数、评分和平均评分、Android/iOS兼容性、初始和应用内支付、数据安全声明、医生参与声明以及FDA/MDR指导。总共审查了986个应用程序和222篇文章,根据纳入结果,最终分析了83个应用程序。这些应用程序根据其主要用途分为六类:教育(n = 8)、液体追踪器(n = 54)、食物含量描述和计算器(n = 11)、诊断(n = 3)、术前和术中应用(n = 4)和支架追踪器(n = 2)。在这些应用中,支持Android、iOS和两者的应用数量分别为36、23和23个。尽管有广泛的应用程序可用于KSD,但医生在其开发,数据安全和功能方面的参与仍然不足。移动健康的进一步发展应该在泌尿科协会的监督下进行,包括患者支持小组,这些应用程序必须定期更新其内容和数据安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Current state of mobile health apps in endourology: a review of mobile platforms in marketplaces and literature.

Current state of mobile health apps in endourology: a review of mobile platforms in marketplaces and literature.

Current state of mobile health apps in endourology: a review of mobile platforms in marketplaces and literature.

Current state of mobile health apps in endourology: a review of mobile platforms in marketplaces and literature.

Several mobile healthcare (mHealth) apps are available in various marketplaces, but there is still concern about their accuracy, data safety, and regulation. The goal of this review was to critically analyze the mobile apps created for education, diagnosis, and medical and surgical treatment of patients with kidney stone disease (KSD), as well as to assess the level of data security, the contribution of physicians in their development and adherence to the Food and Drug Administration (FDA) and Medical Device Regulation (MDR) guidance. A comprehensive literature search was performed using PubMed (September 2022), in the Apple App Store and Google Play store using relevant keywords and inclusion criteria. Information was extracted for the name of the app, primary and additional functionalities, release and last update, number of downloads, number of marks and average rating, Android/iOS compatibility, initial and in-app payments, data safety statement, physician involvement statement, and FDA/MDR guidance. A total of 986 apps and 222 articles were reviewed, of which based on the inclusion, 83 apps were finally analyzed. The apps were allocated to six categories about their primary purpose: education (n = 8), fluid trackers (n = 54), food content description and calculators (n = 11), diagnosis (n = 3), pre- and intra-operative application (n = 4), and stent trackers (n = 2). Of these apps, the number of apps supported for Android, iOS, and both of them were 36, 23, and 23, respectively. Despite a wide range of apps available for KSD, the participation of doctors in their development, data security, and functionality remains insufficient. Further development of mHealth should be carried out properly under the supervision of urological associations involving patient support groups, and these apps must be regularly updated for their content and data security.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信